Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MORABITO, Alessandro")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1
Export

Selection :

  • and

Systemic treatment of gastric cancerMORABITO, Alessandro; CARILLIO, Guido; LONGO, Raffaele et al.Critical reviews in oncology/hematology. 2009, Vol 70, Num 3, pp 216-234, issn 1040-8428, 19 p.Article

Treatment of pulmonary neuroendocrine tumours: State of the art and future developmentsGRIDELLI, Cesare; ROSSI, Antonio; MORABITO, Alessandro et al.Cancer treatment reviews. 2013, Vol 39, Num 5, pp 466-472, issn 0305-7372, 7 p.Article

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non―Small-Cell Lung Cancer: The TORCH Randomized TrialGRIDELLI, Cesare; CIARDIELLO, Fortunato; LEIGHL, Natasha et al.Journal of clinical oncology. 2012, Vol 30, Num 24, pp 3002-3011, issn 0732-183X, 10 p.Article

Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non-Small-Cell Lung CancerDI MAIO, Massimo; CHIODINI, Paolo; PERRONE, Francesco et al.Journal of clinical oncology. 2009, Vol 27, Num 11, pp 1836-1843, issn 0732-183X, 8 p.Article

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trialsDI MAIO, Massimo; SIGNORIELLO, Simona; DANIELE, Bruno et al.Lung cancer. 2012, Vol 76, Num 3, pp 457-464, issn 0169-5002, 8 p.Article

Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trialsGRIDELLI, Cesare; MORABITO, Alessandro; VALMADRE, Giuseppe et al.Lung cancer. 2010, Vol 67, Num 1, pp 86-92, issn 0169-5002, 7 p.Article

Endocrine Effects of Adjuvant Letrozole Compared With Tamoxifen in Hormone-Responsive Postmenopausal Patients With Early Breast Cancer: The HOBOE TrialROSSI, Emanuela; MORABITO, Alessandro; DI MAIO, Massimo et al.Journal of clinical oncology. 2009, Vol 27, Num 19, pp 3192-3197, issn 0732-183X, 6 p.Article

Randomized phase II trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancerGASPARINI, Giampietro; GION, Massimo; ZANCAN, Matelda et al.Breast cancer research and treatment. 2007, Vol 101, Num 3, pp 355-365, issn 0167-6806, 11 p.Article

Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancerNORMANNO, Nicola; ROSSI, Antonio; ROCCO, Gaetano et al.Lung cancer. 2014, Vol 85, Num 2, pp 314-319, issn 0169-5002, 6 p.Article

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 studyMORABITO, Alessandro; GEBBIA, Vittorio; COSTANZO, Raffaele et al.Lung cancer. 2013, Vol 81, Num 1, pp 77-83, issn 0169-5002, 7 p.Article

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients : Safety data from the multicentre phase 3 randomised ELDA trialNUZZO, Francesco; MORABITO, Alessandro; D'AIUTO, Giuseppe et al.Critical reviews in oncology/hematology. 2008, Vol 66, Num 2, pp 171-180, issn 1040-8428, 10 p.Article

The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II studyMORABITO, Alessandro; FILIPPELLI, Gianfranco; ACCURSO, Vincenzo et al.Breast cancer research and treatment. 2003, Vol 78, Num 1, pp 29-36, issn 0167-6806, 8 p.Article

Thrombospondin-1 and -2 in node-negative breast cancer : Correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosisGASPARINI, Giampietro; TOI, Masakazu; BIGANZOLI, Elia et al.Oncology. 2001, Vol 60, Num 1, pp 72-80, issn 0030-2414Article

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III TrialPIGNATA, Sandro; SCAMBIA, Giovanni; VERNAGLIA LOMBARDI, Alessandra et al.Journal of clinical oncology. 2011, Vol 29, Num 27, pp 3628-3635, issn 0732-183X, 8 p.Article

Prolonged control of bone metastases in non-small-cell lung cancer patients treated with gefitinibZAMPA, Germano; MOSCATO, Michele; BRANNIGAN, Brian W et al.Lung cancer. 2008, Vol 60, Num 3, pp 452-454, issn 0169-5002, 3 p.Article

Is tailored therapy feasible in oncology?GASPARINI, Giampietro; LONGO, Raffaele; TORINO, Francesco et al.Critical reviews in oncology/hematology. 2006, Vol 57, Num 1, pp 79-101, issn 1040-8428, 23 p.Article

Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastomaMORABITO, Alessandro; FANELLI, Massimo; CARILLIO, Guido et al.Oncology reports. 2004, Vol 11, Num 1, pp 93-95, issn 1021-335X, 3 p.Article

Angiogenesis sustains tumor dormancy in patients with breast cancer treated with adjuvant chemotherapyGASPARINI, Giampietro; BIGANZOLI, Elia; BONOLDI, Emanuela et al.Breast cancer research and treatment. 2001, Vol 65, Num 1, pp 71-75, issn 0167-6806Article

  • Page / 1